SCHAUMBURG, Ill., July 17, 2014 (GLOBE NEWSWIRE) -- In a release issued earlier today by Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), the time of the teleconference and webcast was 9 a.m. ET. The updated time of the teleconference and webcast is now 10 a.m. ET. The full, updated release follows:
Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced that it will release financial results for the 2014 second quarter pre-market on Wednesday, July 30, 2014 and will host a teleconference and webcast at 10 a.m. ET to review the results.
Interested parties may access the live call by dialing:
Within the United States: 877-293-5456
A live webcast of the teleconference will be available on the company's website at: http://investor.sagentpharma.com/events.cfm.
A replay of the presentation will be available on the Sagent website or by dialing:
The replay will be available until August 12, 2014.
About Sagent Pharmaceuticals, Inc.
Sagent Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectables. Sagent has created a unique global network of resources, comprising rapid development capabilities, sophisticated manufacturing and innovative drug delivery technologies, resulting in an extensive and rapidly expanding pharmaceutical product portfolio that fulfills the evolving needs of patients.
SAGENT CONTACT: Jonathon Singer firstname.lastname@example.org (847) 908-1605